214
Participants
Start Date
December 22, 2023
Primary Completion Date
March 31, 2026
Study Completion Date
June 30, 2026
Titrating sedation targeting both optimal P0.1 and appropriate arousal level
"* Sedation will be adjusted initially to target light sedation (RASS 0 to -2).~* Sedative drugs include IV fentanyl (25-75 mcg/h), midazolam (0.02- 0.1 mg/kg/h), propofol (5-50 mcg/kg/min), dexmedetomidine (0.2-0.7 mcg/kg/h).~* Deep sedation and neuromuscular blocking agents are allowed to facilitate mechanical ventilation adjustment in patients with refractory hypoxemia.~* Dose of cisatracurium is 0.15-0.2 mg/kg intravenous bolus, then continuous infusion at 5 -20 mg/h.~* Then sedation adjustment will be guided by P0.1 measurement.~* If P0.1 value of 1.5-3.5 cmH2O is achieved, no further adjustment is required.~* If P0.1 value \<1.5, sedation will be reduced.~* If P0.1 value \>3.5, sedation will be increased.~* If P0.1 value is still \>3.5 with deep sedation, cisatracurium will be allowed and titrated until P0.1 value \<3.5 cmH2O.~* The study protocol will be continued for 48 hours or until the patients are considered ready for weaning."
Fentanyl
Continuous intravenous infusion of fentanyl 25-75 micrograms/hour
Midazolam
Continuous intravenous infusion of midazolam 0.02 - 0.1 milligrams/kilogram/hour
Propofol
Continuous intravenous infusion of propofol 5 - 50 micrograms/kilogram/minute
Dexmedetomidine
Continuous intravenous infusion of dexmedetomidine 0.2 - 0.7 micrograms/kilogram/hour
Cisatracurium
Continuous intravenous infusion of cisatracurium 5 - 20 milligrams/hour
RECRUITING
Siriraj Hospital, Bangkok
Siriraj Hospital
OTHER